Golden Meditech Holdings Ltd (801):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Golden Meditech Holdings Ltd (801) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11484
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank services, among others. Golden Meditech’s products are used for blood purification, recovery and treatment, among others. The company also provides blood bank for cord blood stem cells storage, and investments in the healthcare industry. It markets its products through a network of distributors in China and Hong Kong. Golden Meditech is headquartered in Hong Kong.

Golden Meditech Holdings Ltd (801) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Golden Meditech Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Golden Meditech Enters into Partnership Agreement with GE Healthcare 11
Golden Meditech and MD Anderson to Form Joint Venture 12
Equity Offering 13
Golden Meditech to Raise up to USD18 Million in Private Placement of Shares 13
Golden Meditech to Raise Funds through Rights Offering of Shares 14
Debt Offering 15
Golden Meditech Raises USD65 Million in Private Placement of 7% Notes Due 2017 15
Golden Meditech to Raises USD20 Million in Convertible Notes Offering 16
China Cord Blood Completes Private Placement Of Note For US$50 Million 17
Acquisition 18
Nanjing Yingpeng Huikang Medical Acquires 65.4% Stake in China Cord Blood 18
Golden Meditech Plans to Acquire Remaining Stake in China Cord Blood 20
Golden Meditech to Acquire Remaining Stake in GM Hospital for USD21 Million 22
Golden Meditech Increases Stake In GM Hospital Group For US$28 Million 24
Golden Meditech Holdings Ltd – Key Competitors 25
Golden Meditech Holdings Ltd – Key Employees 26
Golden Meditech Holdings Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 28
Recent Developments 29
Financial Announcements 29
Jun 27, 2018: Golden Meditech Announces FY2017/2018 Annual Results 29
Jun 25, 2018: Golden Meditech Holdings: Positive Profit Alert 31
Nov 30, 2017: Golden Meditech Announces FY2017/2018 Interim Results 32
Jun 28, 2017: Golden Meditech Announces FY2016/2017 Annual Results 34
Corporate Communications 36
Apr 26, 2018: Golden Meditech: Re-designation of Directors and Changes of Members of Board Committees 36
Apr 16, 2018: Golden Meditech’s Associate, Cellenkos Appoints Alick Sun as Corporate & Business Development SVP 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Golden Meditech Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Golden Meditech Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Golden Meditech Enters into Partnership Agreement with GE Healthcare 11
Golden Meditech and MD Anderson to Form Joint Venture 12
Golden Meditech to Raise up to USD18 Million in Private Placement of Shares 13
Golden Meditech to Raise Funds through Rights Offering of Shares 14
Golden Meditech Raises USD65 Million in Private Placement of 7% Notes Due 2017 15
Golden Meditech to Raises USD20 Million in Convertible Notes Offering 16
China Cord Blood Completes Private Placement Of Note For US$50 Million 17
Nanjing Yingpeng Huikang Medical Acquires 65.4% Stake in China Cord Blood 18
Golden Meditech Plans to Acquire Remaining Stake in China Cord Blood 20
Golden Meditech to Acquire Remaining Stake in GM Hospital for USD21 Million 22
Golden Meditech Increases Stake In GM Hospital Group For US$28 Million 24
Golden Meditech Holdings Ltd, Key Competitors 25
Golden Meditech Holdings Ltd, Key Employees 26
Golden Meditech Holdings Ltd, Other Locations 27
Golden Meditech Holdings Ltd, Subsidiaries 27
Golden Meditech Holdings Ltd, Joint Venture 28

List of Figures
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Golden Meditech Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Golden Meditech Holdings Ltd (801):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iNova Pharmaceuticals (Australia) Pty Ltd:企業の戦略的SWOT分析
    iNova Pharmaceuticals (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Indago Energy Ltd (INK):石油・ガス:M&Aディール及び事業提携情報
    Summary Indago Energy Ltd (Indago), formerly Pryme Energy Ltd is a provider of specialist oil and gas production chemicals. The company offers acquisition, up-gradation, exploration and production services to onshore oil and natural gas. It holds interests in the Newkirk project located in Kay Count …
  • Adynxx Inc (ADYX):企業の財務・戦略的SWOT分析
    Summary Adynxx Inc (Adynxx), formerly known as Alliqua BioMedical, Inc, is a clinical stage biopharmaceutical company. It utilizes AYX transcription factor decoys to create therapies with disease changing properties. The company is involved in the development of transcription factor decoy technology …
  • Aesculap Inc:企業の製品パイプライン分析2018
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • Baxter International Inc.:企業の戦略・SWOT・財務情報
    Baxter International Inc. - Strategy, SWOT and Corporate Finance Report Summary Baxter International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ontario Teachers’ Pension Plan:企業のM&A・事業提携・投資動向
    Ontario Teachers' Pension Plan - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ontario Teachers' Pension Plan Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Otto Energy Ltd (OEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Otto Energy Ltd (Otto Energy), formerly Ottoman Energy Ltd, is an oil and gas company that offers exploration, production, and development of oil and gas properties. The company's products include oil and gas. It operates its exploration properties located in the Offshore Gulf of Mexico such …
  • Hemostemix Inc (HEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Hemostemix Inc (Hemostemix), formerly Theravitae Inc, is a biotechnology company that develops, manufactures and commercializes proprietary autologous cell therapy for the treatment of ischemic diseases. The company’s clinical-stage candidate includes ACP-01, an autologous cell therapy for t …
  • Nexeon MedSystems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nexeon MedSystems Inc (Nexeon) is a bioelectronics company that develops and commercializes therapies and devices for the treatment of cardiovascular diseases. The company’s products categories include nanotechnology-based devices, embolic protection systems, local drug and biologic delivery …
  • Regeneron Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Shanghai Kinetic Medical Co Ltd (300326):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Kinetic Medical Co Ltd (KMC) is a medical device company. The company’s product categories include orthopaedics, ENT products, and vascular surgery products. Its orthopaedic products comprise wire anchor, cervical anterior nail plate system, vertebral dilatation ballon catheter, bon …
  • B&G Foods, Inc.:企業の戦略・SWOT・財務情報
    B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary B&G Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Navigator Holdings Ltd (NVGS):企業の財務・戦略的SWOT分析
    Summary Navigator Holdings Ltd (Navigator) operates as an oil and gas company that offers seaborne transportation of liquefied gases. The company transports ammonia, ethane, ethylene, ambient LPG, petrochemicals and LPG products. It provides fleet management, ship management, gas transportation and …
  • H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析
    H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sysmex Inostics GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Sysmex Inostics GmbH (Sysmex Inostics), formerly Inostics GmbH, a subsidiary of Sysmex Corp, is a molecular diagnostics company that offers blood-based cell-free tumor treatment solutions. The company offers services such as clinical trials, research and development, and testing for physicia …
  • North Eastern Electric Power Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary North Eastern Electric Power Corp Ltd (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and solar sources; …
  • Gadeta BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Gadeta BV (Gadeta) is a biotechnology company, which focuses on the research and development of cellular immunotherapies for the elimination of cancer. The company’s technology platform combines alpha beta T cells engineered to express defined Gamma Delta T cell receptors (TEGs) that demonst …
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • MobileSmith Inc (MOST):企業の財務・戦略的SWOT分析
    Summary MobileSmith Inc (MobileSmith) is a technology company that develops mobile software solutions for enterprise customers. The company’s solutions include hospital application blueprints. Its services comprise mobile strategy, cloud-based hosting, redundant BGP and power, active checks monitore …
  • Wirecard AG:企業のM&A・事業提携・投資動向
    Wirecard AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wirecard AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆